Neuromuscular training reduces the risk of leg injuries in female floorball players.

K. Bennell

DOI: https://doi.org/10.1016/S0004-9514(08)70009-6

Australian Journal of Physiotherapy

Abstract:

What problem does this paper attempt to address?

Immunosenescence profile is associated with increased susceptibility to severe COVID-19

Lucas Haniel Araujo Ventura,Licia Torres,Giovanna Caliman Camatta,Jofer Zamame,Monique Macedo Coelho,Cecilia Horta Ramalho-Pinto,Joao Gervazio,Felipe Caixeta,Leandro Nascimento,Mariana Almeida Oliveira,Vinicius Dantas Martins,Marcos Felipe Oliveira,Murilo Soares Costa,Hugo Itaru Sato,Henrique Cerqueira Guimaraes,Rafael Barbuto,Ana Paula Veiga,Najara Ataide,Gabriela Prandi Caetano,Sarah Rangon,Mauro Junior,Fernanda Calvo Fortes,Luciana Zuccherato,Elaine Speziali Farias,Veronica Coelho,Roberto Avritchir,Rafael Souza,Marina Cacador Ayupe,Caio Loureiro,Ana Clara Mota Neves,Maria Eduarda Passos,Pauline Leite,Santuza Teixeira,Unai Tupinambas,Liza Felicori Vilela,Gabriela Silveira-Nunes,Tatiani Uceli Maioli,Denise Morais Fonseca,Andrea Teixeira-Carvalho,Ana Maria Caetano Faria

DOI: https://doi.org/10.1101/2024.11.18.24317502

2024-11-18

Abstract:In this study we tested the hypothesis that the immunosenescence profile could account for the disproportional susceptibility of the elderly to severe forms of COVID-19. The immunological profiles of volunteers residing in endemic and non-endemic areas for chronic infectious diseases were analyzed at early stage of SARS-CoV-2 infection. A unique signature of inflammatory plasma mediators was identified in COVID-19 volunteers when compared to individuals with other flu-like syndromes. COVID-19 severity correlated with high levels of inflammatory mediators; among them, CXCL9, a serum marker of aging. Patients who progressed to hospitalization displayed high frequencies of CD8+ and CD4+ T cells expressing exhaustion and senescence markers and showed reduced and more mature B cell repertoires, which are typical of senescence. They also had an acceleration of epigenetic age measured by DNA methylation. Therefore, severe COVID-19 correlated with phenotypic, functional, and epigenetic features of accelerated immunosenescence at onset of infection.

Infectious Diseases (except HIV/AIDS)
Immunological characteristics in elderly COVID-19 patients: a post-COVID era analysis

Yunhui Li,Yuan Chen,Jing Liang,Yajie Wang

DOI: https://doi.org/10.3389/fcimb.2024.1450196

IF: 6.073

2024-11-30

Frontiers in Cellular and Infection Microbiology

Abstract:Background: Advanced age is a primary risk factor for adverse COVID-19 outcomes, potentially attributed to immunosenescence and dysregulated inflammatory responses. In the post-pandemic era, with containment measures lifted, the elderly remain particularly susceptible, highlighting the need for intensified focus on immune health management. Methods: A total of 281 elderly patients were enrolled in this study and categorized based on their clinical status at the time of admission into three groups: non-severe (n = 212), severe survivors (n = 49), and severe non-survivors (n = 20). Binary logistic regression analysis was employed to identify independent risk factors associated with disease severity and in-hospital outcomes. The diagnostic performance of risk factors was assessed using the receiver operating characteristic (ROC) curves. Kaplan-Meier survival analysis and log-rank test were utilized to compare the 30-day survival rates. Furthermore, the transcriptomic data of CD4 + T cells were extracted from Gene Expression Omnibus (GEO) database. Gene Set Enrichment Analysis (GSEA) was applied to reveal biological processes and pathways involved. Results: In the comparison between severe and non-severe COVID-19 cases, significant elevations were observed in the neutrophil-to-lymphocyte ratio (NLR), C-reactive protein (CRP), and Serum Amyloid A (SAA) levels, concurrent with a notable reduction in CD8 + T cells, CD4 + T cells, natural killer (NK) cells, and monocytes (all p < 0.05). CD4 + T cells (OR: 0.997 [0.995-1.000], p <0.05) and NLR (OR: 1.03 [1.001-1.060], p <0.05) were independent risk factors affecting disease severity. The diagnostic accuracy for COVID-19 severity, as measured by the area under the curve (AUC) for CD4 + T cells and NLR, was 0.715 (95% CI: 0.645-0.784) and 0.741 (95% CI: 0.675-0.807), respectively. Moreover, patients with elevated NLR or IL-6 levels at admission exhibited significantly shorter survival times. Gene Set Enrichment Analysis (GSEA) revealed several biological pathways that are implicated in the regulation of immune responses and metabolic processes. Conclusions: Lymphocytopenia and the cytokine storm onset are significant predictors of an unfavorable prognosis in elderly patients. The decrease in CD4 + T cells among elderly patients is detrimental to disease recovery, and the biological pathways regulated by these cells could potentially heighten vulnerability to SARS-CoV-2 infection, thereby exacerbating the development of associated complications.

immunology,microbiology
Excess of body weight is associated with accelerated T-cell senescence in hospitalized COVID-19 patients

Mailton Prestes Madruga,Lucas Kich Grun,Letícya Simone Melo Dos Santos,Frederico Orlando Friedrich,Douglas Bitencourt Antunes,Marcella Elesbão Fogaça Rocha,Pedro Luis Silva,Gilson P Dorneles,Paula Coelho Teixeira,Tiago Franco Oliveira,Pedro R T Romão,Lucas Santos,José Claudio Fonseca Moreira,Vinicius Schenk Michaelsen,Marcelo Cypel,Marcos Otávio Brum Antunes,Marcus Herbert Jones,Florencia María Barbé-Tuana,Moisés Evandro Bauer,Gilson P. Dorneles,Pedro R.T. Romão

DOI: https://doi.org/10.1186/s12979-024-00423-6

2024-03-09

Immunity & Ageing

Abstract:Several risk factors have been involved in the poor clinical progression of coronavirus disease-19 (COVID-19), including ageing, and obesity. SARS-CoV-2 may compromise lung function through cell damage and paracrine inflammation; and obesity has been associated with premature immunosenescence, microbial translocation, and dysfunctional innate immune responses leading to poor immune response against a range of viruses and bacterial infections. Here, we have comprehensively characterized the immunosenescence, microbial translocation, and immune dysregulation established in hospitalized COVID-19 patients with different degrees of body weight.

immunology,geriatrics & gerontology,gerontology
COVID-19 and cellular senescence

Clemens A. Schmitt,Tamar Tchkonia,Laura J. Niedernhofer,Paul D. Robbins,James L. Kirkland,Soyoung Lee

DOI: https://doi.org/10.1038/s41577-022-00785-2

IF: 108.555

2022-10-06

Nature Reviews Immunology

Abstract:The clinical severity of coronavirus disease 2019 (COVID-19) is largely determined by host factors. Recent advances point to cellular senescence, an ageing-related switch in cellular state, as a critical regulator of SARS-CoV-2-evoked hyperinflammation. SARS-CoV-2, like other viruses, can induce senescence and exacerbates the senescence-associated secretory phenotype (SASP), which is comprised largely of pro-inflammatory, extracellular matrix-degrading, complement-activating and pro-coagulatory factors secreted by senescent cells. These effects are enhanced in elderly individuals who have an increased proportion of pre-existing senescent cells in their tissues. SASP factors can contribute to a 'cytokine storm', tissue-destructive immune cell infiltration, endothelialitis (endotheliitis), fibrosis and microthrombosis. SASP-driven spreading of cellular senescence uncouples tissue injury from direct SARS-CoV-2-inflicted cellular damage in a paracrine fashion and can further amplify the SASP by increasing the burden of senescent cells. Preclinical and early clinical studies indicate that targeted elimination of senescent cells may offer a novel therapeutic opportunity to attenuate clinical deterioration in COVID-19 and improve resilience following infection with SARS-CoV-2 or other pathogens.

immunology
Elevated CD4+ T Cell Senescence Associates with Impaired Immune Responsiveness in Severe COVID-19

Jie Zhang,Chun Chang,Zhaoyuan Liang,Tingting Hu,Zhongnan Yin,Ying Liang,Ting Zhang,Yanling Ding,Xianlong Li,Xiaoyan Gai,Xiaoxue Yang,Xin Li,Xixuan Dong,Jiaqi Ren,Yafei Rao,Jun Wang,Jianling Yang,Lixiang Xue,Yongchang Sun

DOI: https://doi.org/10.14336/ad.2024.0214-2

2024-01-01

Aging and Disease

Abstract:Aging is a critical risk factor for unfavorable clinical outcomes among COVID-19 patients and may impact vaccine efficacy. However, whether the senescence of T cells is associated with severe COVID-19 outcome in elderly individuals is unclear. Using flow cytometry, we analyzed the frequency of senescent T cells (Tsens) in peripheral blood from 100 hospitalized elderly COVID-19 patients and compared differences between those with mild/moderate and severe/critical illness. We also assessed correlations between the percentage of Tsens and the quantity and quality of spike-specific antibodies by ELISA, neutralizing antibody test kit, and ELISPOT assay respectively, the cytokine production profile of COVID-19 reactive T cells, and plasma soluble factors by cytometric bead array (CBA). Our study found a significantly elevated level of CD4+ Tsens in patients with severe/critical disease compared to those with mild/moderate illness. Patients with a higher level of CD4+ Tsens (>19.78%) showed a decreased survival rate compared to those with a lower level (≤19.78%). This is more pronounced among patients with breakthrough infections. The percentage of CD4+ Tsens was negatively correlated with spike-specific antibody titers, neutralization ability, and COVID-19 reactive IL-2+CD4+ T cells. In addition, spike-specific antibody levels were positively correlated with IL-2 producing T cells and plasma IL-2 amount. Mechanistically, with defective CD40L, T cells from patients with CD4+ Tsens >19.78% were unable to support B cell proliferation and differentiation. Our data demonstrate that the percentage of CD4+ Tsens in peripheral blood may serve as a reliable biomarker for the prognosis of severe COVID-19 patients, especially in breakthrough infections. Therefore, restoring the immune response of CD4+ Tsens may be key to preventing severe illness and improving vaccine efficacy in older adults.

geriatrics & gerontology,gerontology
Immune cell population and cytokine profiling suggest age dependent differences in the response to SARS-CoV-2 infection

Larraitz Aragon,Andrea Iribarren-López,Ainhoa Alberro,Leire Iparraguirre,Miguel Von Wichmann,Jose María Marimon,Nagore Saiz-Calderon,Julia Agudo,M. Isabel Gálvez,M. Carmen Cipitria,Alvaro Prada,David Otaegui

DOI: https://doi.org/10.3389/fragi.2023.1108149

2023-02-13

Frontiers in Aging

Abstract:Aging population is at higher risk of developing severe COVID-19, including hospitalization and death. In this work, to further understand the relationship between host age-related factors, immunosenescence/exhaustion of the immune system and the response to the virus, we characterized immune cell and cytokine responses in 58 COVID-19 patients admitted to the hospital and 40 healthy controls of different age ranges. Lymphocyte populations and inflammatory profiles were studied in blood samples, using different panels of multicolor flow cytometry. As expected, our analysis reveals differences at both the cellular and cytokine level in COVID-19 patients. Interestingly, when the age range analysis was carried out, the immunological response to the infection was found to differ with age, being especially affected in the group of 30–39 years. In this age range, an increased exhausted T cell response and a decrease of naïve T helper lymphocytes was found in patients, as well as a reduced concentration of the proinflammatory TNF, IL-1β and IL-8 cytokines. Besides, the correlation between age and the study variables was evaluated, and multiple cell types and interleukins were found to correlate with donor age. Notably, the correlations of T helper naïve and effector memory cells, T helper 1–17 cells, TNF, IL-10, IL-1β, IL-8, among others, showed differences between healthy controls and COVID-19 patients. Our findings, in the context of other previous studies, suggest that aging affects the behavior of the immune system in COVID-19 patients. They suggest that young individuals are able to mount an initial response to SARS-CoV-2, but some of them present an accelerated exhaustion of the cell response and an insufficient inflammatory response, resulting in a moderate to severe COVID-19. On the other hand, in older patients there is a smaller immune cell response to the virus, reflected in fewer differences in immune populations between COVID-19 patients and controls. Nevertheless, old patients show more evidence of an inflammatory phenotype, suggesting that the underlying inflammation associated with their age is exacerbated by the SARS-CoV-2 infection.
Increased levels of GM-CSF and CXCL10 and low CD8+ memory stem T Cell count are markers of immunosenescence and severe COVID-19 in older people

Johanne Poisson,Carine El-Sissy,Arnaud Serret-Larmande,Nikaïa Smith,Morgane Lebraud,Jean-Loup Augy,Catherine Conti,Cécile Gonnin,Benjamin Planquette,Jean-Benoît Arlet,Bertrand Hermann,Bruno Charbit,Jean Pastre,Floriane Devaux,Cyrielle Ladavière,Lydie Lim,Pauline Ober,Johanna Cannovas,Lucie Biard,Marie-Christelle Gulczynski,Noémie Blumenthal,Hélène Péré,Camille Knosp,Alain Gey,Nadine Benhamouda,Juliette Murris,David Veyer,Eric Tartour,Jean-Luc Diehl,Darragh Duffy,Elena Paillaud,Clémence Granier

DOI: https://doi.org/10.1186/s12979-024-00430-7

2024-05-09

Immunity & Ageing

Abstract:Ageing leads to altered immune responses, resulting in higher susceptibility to certain infections in the elderly. Immune ageing is a heterogeneous process also associated with inflammaging, a low-grade chronic inflammation. Altered cytotoxic T cell responses and cytokine storm have previously been described in severe COVID-19 cases, however the parameters responsible for such immune response failures are not well known. The aim of our study was to characterize CD8 + T cells and cytokines associated with ageing, in a cohort of patients aged over 70 years stratified by COVID-19 severity.

immunology,geriatrics & gerontology,gerontology
Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity

Carolyn Rydyznski Moderbacher,Sydney I. Ramirez,Jennifer M. Dan,Alba Grifoni,Kathryn M. Hastie,Daniela Weiskopf,Simon Belanger,Robert K. Abbott,Christina Kim,Jinyong Choi,Yu Kato,Eleanor G. Crotty,Cheryl Kim,Stephen A. Rawlings,Jose Mateus,Long Ping Victor Tse,April Frazier,Ralph Baric,Bjoern Peters,Jason Greenbaum,Erica Ollmann Saphire,Davey M. Smith,Alessandro Sette,Shane Crotty

DOI: https://doi.org/10.1016/j.cell.2020.09.038

IF: 64.5

2020-11-01

Cell

Abstract:Adaptive immune responses limit COVID-19 disease severityMultiple coordinated arms of adaptive immunity control better than partial responsesCXCL10 may be a biomarker of impaired T cell responses in acute COVID-19Aging and scarcity of naive T cells may be linked risk factors for severe COVID-19Limited knowledge is available on the relationship between antigen-specific immune responses and COVID-19 disease severity. We completed a combined examination of all three branches of adaptive immunity at the level of SARS-CoV-2-specific CD4+ and CD8+ T cell and neutralizing antibody responses in acute and convalescent subjects. SARS-CoV-2-specific CD4+ and CD8+ T cells were each associated with milder disease. Coordinated SARS-CoV-2-specific adaptive immune responses were associated with milder disease, suggesting roles for both CD4+ and CD8+ T cells in protective immunity in COVID-19. Notably, coordination of SARS-CoV-2 antigen-specific responses was disrupted in individuals > 65 years old. Scarcity of naive T cells was also associated with ageing and poor disease outcomes. A parsimonious explanation is that coordinated CD4+ T cell, CD8+ T cell, and antibody responses are protective, but uncoordinated responses frequently fail to control disease, with a connection between ageing and impaired adaptive immune responses to SARS-CoV-2.

cell biology,biochemistry & molecular biology
CD4+T cell senescence is associated with reduced reactogenicity in severe/critical COVID-19

Jie Zhang,Chun Chang,Zhaoyuan Liang,Tingting Hu,Zhongnan Yin,Ying Liang,Biying Zhang,Yanling Ding,Xianlong Li,Xiaoyan Gai,Xiaoqi Yang,Li X,Xixuan Dong,Jiaqi Ren,Yafei Rao,Jun Wang,Jun Yang,Yongchang Sun,Lixiang Xue

DOI: https://doi.org/10.1101/2023.08.04.551565

2023-01-01

Abstract:Abstract Background Aging is a critical risk factor for unfavorable clinical outcomes among COVID-19 patients and may affect vaccine efficacy. However, whether the senescence of T cells impact the progression to severe COVID-19 in the elderly individuals remains unclear. Methods By using flow cytometry, we analyzed the frequency of senescent T cells (Tsens) in the peripheral blood from 100 elderly patients hospitalized for COVID-19 and compared the difference between mild/moderate and severe/critical illness. We also assessed correlations between the percentage of Tsens and the quantity and quality of spike-specific antibodies by ELISA, neutralizing antibody test kit and Elispot assay respectively, cytokine production profile of COVID-19 reactive T cells as well as plasma soluble factors by cytometric bead array (CBA). Results We found a significant elevated level of CD4 + Tsens in severe/critical disease compared to mild/moderate illness and patients with a higher level of CD4 + Tsens (>19.78%) showed a decreased survival rate as compared to those with a lower level (<19.78%), especially in the breakthrough infection. The percentage of CD4 + Tsens was negatively correlated with spike-specific antibody titers, neutralization ability and COVID-19 reactive IL-2 + CD4 + T cells. Additionally, IL-2 producing T cells and plasma levels of IL-2 were positively correlated with antibody levels. Conclusion Our data illustrated that the percentage of CD4 + Tsens in the peripheral blood could act as an efficient biomarker for the capacity of spike-specific antibody production and the prognosis of severe COVID-19, especially in the breakthrough infection. Therefore, restoration of the immune response of CD4 + Tsens is one of the key factors to prevent severe illness and improve vaccine efficacy in older adults.
CD4+ T cell senescence is associated with reduced reactogenicity in severe/critical COVID-19

Jie Zhang,Chun Chang,Zhaoyuan Liang,Tingting Hu,Zhongnan Yin,Ying Liang,Ting Zhang,Yanling Ding,Xianlong Li,Xiaoyan Gai,Xiaoxue Yang,Xin Li,Xixuan Dong,Jiaqi Ren,Yafei Rao,Jun Wang,Jianling Yang,Lixiang Xue,Yongchang Sun

DOI: https://doi.org/10.1101/2023.08.04.551565

2023-01-01

Abstract:Background Aging is a critical risk factor for unfavorable clinical outcomes among COVID-19 patients and may affect vaccine efficacy. However, whether the senescence of T cells impact the progression to severe COVID-19 in the elderly individuals remains unclear. Methods By using flow cytometry, we analyzed the frequency of senescent T cells (Tsens) in the peripheral blood from 100 elderly patients hospitalized for COVID-19 and compared the difference between mild/moderate and severe/critical illness. We also assessed correlations between the percentage of Tsens and the quantity and quality of spike-specific antibodies by ELISA, neutralizing antibody test kit and Elispot assay respectively, cytokine production profile of COVID-19 reactive T cells as well as plasma soluble factors by cytometric bead array (CBA). Results We found a significant elevated level of CD4+ Tsens in severe/critical disease compared to mild/moderate illness and patients with a higher level of CD4+ Tsens (>19.78%) showed a decreased survival rate as compared to those with a lower level (<19.78%), especially in the breakthrough infection. The percentage of CD4+ Tsens was negatively correlated with spike-specific antibody titers, neutralization ability and COVID-19 reactive IL-2+ CD4+ T cells. Additionally, IL-2 producing T cells and plasma levels of IL-2 were positively correlated with antibody levels. Conclusion Our data illustrated that the percentage of CD4+ Tsens in the peripheral blood could act as an efficient biomarker for the capacity of spike-specific antibody production and the prognosis of severe COVID-19, especially in the breakthrough infection. Therefore, restoration of the immune response of CD4+ Tsens is one of the key factors to prevent severe illness and improve vaccine efficacy in older adults. ### Competing Interest Statement The authors have declared no competing interest. * ACE : angiotensin converting enzyme BMI : body mass index CD : cluster of differentiation COVID : corona virus disease CBA : cytometric bead array CRP : C-reactive protein CM : central memory COPD : chronic obstructive pulmonary disease CXCL : C-X-C motif ligand CCL : C-C motif ligand DC : dendritic cells ELISA : enzyme-linked immunosorbent assay Elispot : enzyme-linked immunoblot EM : effector memory EMRA : terminally differentiated effector cells EDTA : ethylene diamine tetraacetic acid IL : interleukin ICU : intensive care unit IgG : immunoglobulin G IgM : immunoglobulin M IFN-γ : interferon-γ LDH : lactate dehydrogenase PCT : procalcitonin PLT : platelet PBMCs : peripheral blood mononuclear cells RBD : receptor binding domain RBC : red blood cell RR : respiratory rate SARS-CoV-2 : severe acute respiratory syndrome coronavirus 2 SASP : senescent associated secretory phenotype Tsens : senescent T cells TNF-α : tumor necrosis factor Th : helper T cells WT : wild type
SARS-CoV-2 infection represents a high risk for the elderly: analysis of pathogenesis

Adriana Pedreañez,Jesus Mosquera-Sulbaran,Nelson Muñoz

DOI: https://doi.org/10.1007/s00705-021-05042-w

IF: 2.685

2021-03-22

Archives of Virology

Abstract:As people get older, age-related alterations occur that lead to increased susceptibility to disease. In the current COVID-19 pandemic, older people are particularly susceptible to a SARS-CoV-2 infection developing into severe disease. The objective of this review was to examine the literature regarding factors that may explain the tendency of this population to develop severe COVID-19. Research articles considered in this review were searched for in EMBASE, PubMed, and Web of Science from December 2019 to December 2020. Citations were screened by two independent reviewers. Studies of the immune system in older individuals found alterations in both the adaptive and innate immune systems. The adaptive system is depressed in its functions, and the innate system is in a pro-inflammatory state that can lead to chronic disease. This pro-inflammatory state may be related to a severe course of disease in COVID-19. This review shows that the level of evidence supporting an association between immune alterations in the elderly and susceptibly to severe progression of SARS-CoV-2 infection is generally consistent. Preventive measures such as early antiviral treatment are of key importance for prevention of severe progression of COVID19.

virology
Implications of Low-grade Inflammation in SARS-CoV-2 Immunopathology

Anamary Suárez-Reyes,Carlos A Villegas-Valverde

DOI: https://doi.org/10.37757/MR2021.V23.N2.4

Abstract:Introduction: Advanced age and chronic disease comorbidities are indicators of poor prognosis in COVID-19 clinical progression. Fatal outcomes in patients with these characteristics are due to a dysfunctional immune response. Understanding COVID-19's immunopathogenesis helps in designing strategies to prevent and mitigate complications during treatment. Objective: Describe the main immunopathogenic alterations of COVID-19 in patients of advanced age or with chronic non-communicable diseases. Data acquisition: We carried out a bibliographic search of primary references in PubMed, Elsevier, Science Direct and SciELO. A total of 270 articles met our initial search criteria. Duplicate articles or those unrelated to at least one chronic comorbidity, senescence or inflammation and those that studied only patient clinical characteristics, laboratory tests or treatments were excluded. Finally, our selection included 124 articles for analysis: 10 meta-analyses, 24 original research articles, 67 review articles, 9 editorials, 9 comments, 3 books and 2 websites. Development: Hypertension and diabetes mellitus are the most common comorbidities in COVID-19 patients. Risk of developing severe manifestations of the disease, including death, is increased in senescent and obese patients and those with cardiovascular disease, cancer or chronic obstructive pulmonary disease. Low-grade chronic inflammation is characteristic of all these conditions, reflected in a pro-inflammatory state, endothelial dysfunction, and changes to innate immunity; mainly of the monocyte-macrophage system with changes in polarization, inflammation, cytotoxicity and altered antigenic presentation. In the case of SARS-CoV-2 infection, mechanisms involved in acute inflammation overlap with the patient's pro-inflammatory state, causing immune system dysfunction. SARS-CoV-2 infection amplifies already-existing alterations, causing failures in the immune system's control mechanisms. The resulting cytokine storm causes an uncontrolled systemic inflammatory response marked by high serum levels of inflammatory biomarkers and a pro-inflammatory cytokine profile with decompensation of underlying diseases. In asthma, chronic eosinophilic inflammation protects against infection by producing a reduced interferon-mediated response and a reduced number of ACE2 receptors. Conclusions: Low-grade chronic inflammation present in advanced age and chronic diseases-but not in bronchial asthma-produces a pro-inflammatory state that triggers a dysregulated immune response, favoring development of severe forms of COVID-19 and increasing lethality.
Analysis of peripheral lymphocyte subsets and T-cell exhaustion in SARS-CoV-2 Infection

Şadan Soyyiğit,Dilek Öksüzer Çimşir,Ali Öncül,Aysel Pekel,Ferda Öner Erkekol,Rahmet Güner,Seval İzdeş,Derya Gökmen,Şerife Gökbulut Bektaş,Osman İnan,Emin Gemcioğlu,Abdurrezzak Yılmaz,Enes Seyda Şahiner,İmran Hasanoğlu,Ayşe Kaya Kalem,Bircan Kayaaslan,Fatma Eser,İhsan Ateş

DOI: https://doi.org/10.5578/tt.202402929

Tuberk Toraks

Abstract:Introduction: : Immune responses against Coronavirus (SARS-CoV-2) may be highly complex. It has been suggested that T-cell fatigue develops due to continuous stimulation of T-cells by SARS-CoV-2 in Coronavirus disease-2019 (COVID-19). It was aimed to assess peripheral lymphocyte subsets and T-cell exhaustion in various clinical courses of the disease in patients diagnosed with COVID-19. Materials and methods: This study included 150 patients who were assigned into the "mild-to-moderate disease" group, or "severe disease" group based on their clinical and laboratory characteristics. Peripheral lymphocyte subsets and T-cell exhaustion markers [programmed cell death protein 1 (PD-1) and T-cell immunoglobulin and mucin-domain containing-3 (Tim-3)] were determined in the peripheral blood using flow cytometry. Result: Mean (±SD) age was 53.3 ± 14.5 years, and female to male ratio was 55/95. In the mild-to-moderate disease (MMD) group, 55 patients had pneumonia and 20 patients had COVID-19 without pneumonia. In the severe disease (SD) group, 43 patients had severe pneumoniae and 32 patients were in critical condition. Lymphocyte counts were less than 1.0 x 109/L in 69.3% of the patients in the SD group, and the difference between the MMD group and SD group was statistically significant (p= 0.001). Total T cells, CD4+ and CD8+ T-cell counts were significantly lower in the SD group vs. MMD group (p< 0.001, p< 0.001, p< 0.001, respectively). PD-1 expression by CD8+ and CD4 T+ cells was higher (p= 0.042, p= 0.029, respectively) and Tim-3 expression from CD4 T+ cells was lower (p= 0.000) in the SD group vs. MMD group. Serum IFN-γ levels were not statistically different in the MMD and SD groups (p= 0.2). Conclusions: T-cell counts may be significantly reduced along with an increased expression of the T-cell exhaustion marker PD-1 in severe COVID-19, but Tim-3 expression was not increased in our study patients.
Generation of Cytotoxic T Cells and Dysfunctional CD8 T Cells in Severe COVID-19 Patients

Sarah Cristina Gozzi-Silva,Luana de Mendonça Oliveira,Ricardo Wesley Alberca,Natalli Zanete Pereira,Fábio Seiti Yoshikawa,Anna Julia Pietrobon,Tatiana Mina Yendo,Milena Mary de Souza Andrade,Yasmim Alefe Leuzzi Ramos,Cyro Alves Brito,Emily Araujo Oliveira,Danielle Rosa Beserra,Raquel Leão Orfali,Valéria Aoki,Alberto Jose da Silva Duarte,Maria Notomi Sato

DOI: https://doi.org/10.3390/cells11213359

IF: 6

2022-10-26

Cells

Abstract:COVID-19, the infectious disease caused by SARS-CoV-2, has spread on a pandemic scale. The viral infection can evolve asymptomatically or can generate severe symptoms, influenced by the presence of comorbidities. Lymphopenia based on the severity of symptoms in patients affected with COVID-19 is frequent. However, the profiles of CD4+ and CD8+ T cells regarding cytotoxicity and antiviral factor expression have not yet been completely elucidated in acute SARS-CoV-2 infections. The purpose of this study was to evaluate the phenotypic and functional profile of T lymphocytes in patients with moderate and severe/critical COVID-19. During the pandemic period, we analyzed a cohort of 62 confirmed patients with SARS-CoV-2 (22 moderate cases and 40 severe/critical cases). Notwithstanding lymphopenia, we observed an increase in the expression of CD28, a co-stimulator molecule, and activation markers (CD38 and HLA-DR) in T lymphocytes as well as an increase in the frequency of CD4+ T cells, CD8+ T cells, and NK cells that express the immunological checkpoint protein PD-1 in patients with a severe/critical condition compared to healthy controls. Regarding the cytotoxic profile of peripheral blood mononuclear cells, an increase in the response of CD4+ T cells was already observed at the baseline level and scarcely changed upon PMA and Ionomycin stimulation. Meanwhile, CD8+ T lymphocytes decreased the cytotoxic response, evidencing a profile of exhaustion in patients with severe COVID-19. As observed by t-SNE, there were CD4+ T-cytotoxic and CD8+ T with low granzyme production, evidencing their dysfunction in severe/critical conditions. In addition, purified CD8+ T lymphocytes from patients with severe COVID-19 showed increased constitutive expression of differentially expressed genes associated with the caspase pathway, inflammasome, and antiviral factors, and, curiously, had reduced expression of TNF-α. The cytotoxic profile of CD4+ T cells may compensate for the dysfunction/exhaustion of TCD8+ in acute SARS-CoV-2 infection. These findings may provide an understanding of the interplay of cytotoxicity between CD4+ T cells and CD8+ T cells in the severity of acute COVID-19 infection.

cell biology
Evidence That SARS-CoV-2 Induces Lung Cell Senescence: Potential Impact on COVID-19 Lung Disease

Larissa Lipskaia,Pauline Maisonnasse,Charles Fouillade,Valentin Sencio,Quentin Pascal,Jean-Michel Flaman,Emmanuelle Born,Arturo Londono-Vallejo,Roger Le Grand,David Bernard,François Trottein,Serge Adnot

DOI: https://doi.org/10.1165/rcmb.2021-0205LE

IF: 7.748

2022-01-01

American Journal of Respiratory Cell and Molecular Biology

Abstract:To the Editor : Older age is a major risk factor for severe coronavirus disease (COVID-19) (1). Understanding the biological mechanisms linking age to the pathogenesis of COVID-19 is essential for developing preventive and therapeutic strategies. We hypothesized that cell senescence, a basic aging process that plays a pivotal role in health deterioration and diseases, particularly those targeting the lung (2), is involved in the pathogenesis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–induced lung disease, including the development of long-lasting lung alterations. Senescent cells exhibit a stable proliferation arrest and acquire a specific senescence-associated secretory phenotype characterized by the release of inflammatory cytokines, immune modulators, proteases, profibrotic factors, and various effectors that can alter tissue organization and function (3). Senescence is triggered by a myriad of stressors that promote a DNA damage response leading to p53-dependent upregulation of the CDK inhibitor p21 and/or expression of p16, which is used as a reliable marker of senescent cells. Cell senescence is pivotal in age-associated lung diseases, notably lung emphysema, fibrosis, and chronic obstructive pulmonary disease (2, 4–6). In recent studies, SARS-CoV-2 Spike protein-1 was shown to exacerbate the senescence-associated secretory phenotype of human senescent cells, thereby contributing to the exuberant inflammatory response seen in severe COVID-19. Targeting senescent cells using senolytic drugs reduced mortality in old mice infected with a mouse β-coronavirus (7). To further evaluate potential links between SARS-CoV-2 infection and cell senescence, we analyzed publicly available single-cell RNA sequencing data sets obtained using BAL fluid (BALF) cells from patients with moderate or severe-to-critical COVID-19 (8). We also monitored lung cell senescence in SARS-CoV-2–infected macaques, which constitute a relevant model for studying human COVID-19 (9).

biochemistry & molecular biology,cell biology,respiratory system
Delayed viral clearance and altered inflammatory responses resulted in increased severity of SARS-CoV-2 infection in aged mice.

Émile Lacasse,Isabelle Dubuc,Leslie Gudimard,Ana Claudia Dos Santos Pereira Andrade,Annie Gravel,Karine Greffard,Alexandre Chamberland,Camille Oger,Jean-Marie Galano,Thierry Durand,Éric Philipe,Marie-Renée Blanchet,Jean-François Bilodeau,Louis Flamand

DOI: https://doi.org/10.1101/2024.10.03.616431

2024-10-03

Abstract:Since the onset of the COVID-19 pandemic, advanced age has emerged as a major predictor of disease severity. Epidemiological investigations consistently demonstrate an overrepresentation of the elderly in COVID-19 hospitalizations and fatalities. Despite this, a comprehensive understanding of the molecular mechanisms explaining how old age constitutes a critical risk factor remains elusive. To unravel this, we designed an animal study, juxtaposing the course of COVID-19 in young adults (2 months) and geriatric (15-22 months) mice. Both groups of K18(hACE2) mice were intranasally exposed to 500 TCID50 of the SARS-CoV-2 Delta variant with a variety of outcomes assessed on days 3, 5, and 7 post-infections (DPI). Analyses included pulmonary cytokines, RNA, viral loads, lipidomic profiles, and histological assessments, with a concurrent evaluation of the percentage of mice reaching humane endpoints. The findings unveiled notable distinctions between the two groups, with aged mice exhibiting impaired viral clearance at 7 DPI, correlating with diminished survival rates together with an absence of weight loss recovery at 6-7 DPI. Additionally, elderly-infected mice exhibited a deficient Th1 response characterized by diminished productions of IFNg, CCL2, CCL3, and CXCL9 relative to younger mice. Furthermore, mass-spectrometry analysis of the lung lipidome indicated altered expression of several lipids with immunomodulatory and pro-resolution effects in aged mice such as Resolvin, HOTrEs, and NeuroP, but also DiHOMEs-related ARDS. Collectively, disease severity implies a dysregulation of the antiviral response in elderly-infected mice relative to younger mice, resulting in compromised viral clearance and a more unfavorable prognosis. This underscores the potential efficacy of immunomodulatory treatments for elderly subjects experiencing symptoms of severe COVID-19.

Microbiology
Distinct SARS-CoV-2 specific NLRP3 and IL-1β responses in T cells of aging patients during acute COVID-19 infection

Shanmuga Sundaram Mahalingam,Sangeetha Jayaraman,Adhvika Arunkumar,Holly M Dudley,Donald D Anthony,Carey L Shive,Jeffrey M Jacobson,Pushpa Pandiyan

DOI: https://doi.org/10.3389/fimmu.2023.1231087

2023-09-18

Abstract:Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes Coronavirus Disease 2019 (COVID-19) that presents with varied clinical manifestations ranging from asymptomatic or mild infections and pneumonia to severe cases associated with cytokine storm, acute respiratory distress syndrome (ARDS), and even death. The underlying mechanisms contributing to these differences are unclear, although exacerbated inflammatory sequelae resulting from infection have been implicated. While advanced aging is a known risk factor, the precise immune parameters that determine the outcome of SARS-CoV-2 infection in elderly individuals are not understood. Here, we found aging-associated (age ≥61) intrinsic changes in T cell responses when compared to those from individuals aged ≤ 60, even among COVID-positive patients with mild symptoms. Specifically, when stimulated with SARS-CoV-2 peptides in vitro, peripheral blood mononuclear cell (PBMC) CD4+ and CD8+ T cells from individuals aged ≥61 showed a diminished capacity to produce IFN-γ and IL-1β. Although they did not have severe disease, aged individuals also showed a higher frequency of PD-1+ cells and significantly diminished IFN-γ/PD-1 ratios among T lymphocytes upon SARS-CoV-2 peptide stimulation. Impaired T cell IL-1β expression coincided with reduced NLRP3 levels in T lymphocytes. However, the expression of these molecules was not affected in the monocytes of individuals aged ≥61. Together, these data reveal SARS-CoV-2-specific CD4+ and CD8+ T-cell intrinsic cytokine alterations in the individuals older than 61 and may provide new insights into dysregulated COVID-directed immune responses in the elderly.
COVID‐19 is an emergent disease of aging

Didac Santesmasses,José Pedro Castro,Aleksandr A. Zenin,Anastasia V. Shindyapina,Maxim V. Gerashchenko,Bohan Zhang,Csaba Kerepesi,Sun Hee Yim,Peter O. Fedichev,Vadim N. Gladyshev

DOI: https://doi.org/10.1111/acel.13230

IF: 11.005

2020-10-01

Aging Cell

Abstract:COVID‐19 is an ongoing pandemic caused by the SARS‐CoV‐2 coronavirus that poses one of the greatest challenges to public health in recent years. SARS‐CoV‐2 is known to preferentially target older subjects and those with pre‐existing conditions, but the reason for this age dependence is unclear. Here, we found that the case fatality rate for COVID‐19 grows exponentially with age in all countries tested, with the doubling time approaching that of all‐cause human mortality. In addition, men and those with multiple age‐related diseases are characterized by increased mortality. Moreover, similar mortality patterns were found for all‐cause pneumonia. We further report that the gene expression of ACE2, the SARS‐CoV‐2 receptor, grows in the lung with age, except for subjects on a ventilator. Together, our findings establish COVID‐19 as an emergent disease of aging, and age and age‐related diseases as its major risk factors. In turn, this suggests that COVID‐19, and deadly respiratory diseases in general, may be targeted, in addition to antiviral approaches, by approaches that target the aging process.

cell biology,geriatrics & gerontology
A human circulating immune cell landscape in aging and COVID-19

Yingfeng Zheng,Xiuxing Liu,Wenqing Le,Lihui Xie,He Li,Wen Wen,Si Wang,Shuai Ma,Zhaohao Huang,Jinguo Ye,Wen Shi,Yanxia Ye,Zunpeng Liu,Moshi Song,Weiqi Zhang,Jing-Dong J. Han,Juan Carlos Izpisua Belmonte,Chuanle Xiao,Jing Qu,Hongyang Wang,Guang-Hui Liu,Wenru Su

DOI: https://doi.org/10.1007/s13238-020-00762-2

2020-08-11

Abstract:Abstract Age-associated changes in immune cells have been linked to an increased risk for infection. However, a global and detailed characterization of the changes that human circulating immune cells undergo with age is lacking. Here, we combined scRNA-seq, mass cytometry and scATAC-seq to compare immune cell types in peripheral blood collected from young and old subjects and patients with COVID-19. We found that the immune cell landscape was reprogrammed with age and was characterized by T cell polarization from naive and memory cells to effector, cytotoxic, exhausted and regulatory cells, along with increased late natural killer cells, age-associated B cells, inflammatory monocytes and age-associated dendritic cells. In addition, the expression of genes, which were implicated in coronavirus susceptibility, was upregulated in a cell subtype-specific manner with age. Notably, COVID-19 promoted age-induced immune cell polarization and gene expression related to inflammation and cellular senescence. Therefore, these findings suggest that a dysregulated immune system and increased gene expression associated with SARS-CoV-2 susceptibility may at least partially account for COVID-19 vulnerability in the elderly.

cell biology
Delayed bystander CD8 T cell activation, early immune pathology and persistent dysregulation characterise severe COVID-19

Laura Bergamaschi,Federica Mescia,Lorinda Turner,Aimee Hanson,Prasanti Kotagiri,Benjamin J. Dunmore,Hélène Ruffieux,Aloka De Sa,Oisín Huhn,Michael D Morgan,Pehuen Pereyra Gerber,Mark R. Wills,Stephen Baker,Fernando J Calero-Nieto,Rainer Doffinger,Gordon Dougan,Anne Elmer,Ian G Goodfellow,Ravindra K. Gupta,Myra Hosmillo,Kelvin Hunter,Nathalie Kingston,Paul J. Lehner,Nicholas J. Matheson,Jeremy K. Nicholson,Anna M. Petrunkina,Sylvia Richardson,Caroline Saunders,James E.D. Thaventhiran,Erik J. M. Toonen,Michael P. Weekes,Berthold Göttgens,Mark Toshner,Christoph Hess,John R. Bradley,Paul A. Lyons,Kenneth G.C. Smith,

DOI: https://doi.org/10.1101/2021.01.11.20248765

2021-01-15

Abstract:Summary In a study of 207 SARS-CoV2-infected individuals with a range of severities followed over 12 weeks from symptom onset, we demonstrate that an early robust bystander CD8 T cell immune response, without systemic inflammation, is characteristic of asymptomatic or mild disease. Those presenting to hospital had delayed bystander responses and systemic inflammation already evident at around symptom onset. Such early evidence of inflammation suggests immunopathology may be inevitable in some individuals, or that preventative intervention might be needed before symptom onset. Viral load does not correlate with the development of this pathological response, but does with its subsequent severity. Immune recovery is complex, with profound persistent cellular abnormalities correlating with a change in the nature of the inflammatory response, where signatures characteristic of increased oxidative phosphorylation and reactive-oxygen species-associated inflammation replace those driven by TNF and IL-6. These late immunometabolic inflammatory changes and unresolved immune defects may have clinical implications.

Neuromuscular training reduces the risk of leg injuries in female floorball players.

Immunosenescence profile is associated with increased susceptibility to severe COVID-19

Immunological characteristics in elderly COVID-19 patients: a post-COVID era analysis

Excess of body weight is associated with accelerated T-cell senescence in hospitalized COVID-19 patients

COVID-19 and cellular senescence

Elevated CD4+ T Cell Senescence Associates with Impaired Immune Responsiveness in Severe COVID-19

Immune cell population and cytokine profiling suggest age dependent differences in the response to SARS-CoV-2 infection

Increased levels of GM-CSF and CXCL10 and low CD8+ memory stem T Cell count are markers of immunosenescence and severe COVID-19 in older people

Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity

CD4<sup>+</sup>T cell senescence is associated with reduced reactogenicity in severe/critical COVID-19

CD4+ T cell senescence is associated with reduced reactogenicity in severe/critical COVID-19

SARS-CoV-2 infection represents a high risk for the elderly: analysis of pathogenesis

Implications of Low-grade Inflammation in SARS-CoV-2 Immunopathology

Analysis of peripheral lymphocyte subsets and T-cell exhaustion in SARS-CoV-2 Infection

Generation of Cytotoxic T Cells and Dysfunctional CD8 T Cells in Severe COVID-19 Patients

Evidence That SARS-CoV-2 Induces Lung Cell Senescence: Potential Impact on COVID-19 Lung Disease

Delayed viral clearance and altered inflammatory responses resulted in increased severity of SARS-CoV-2 infection in aged mice.

Distinct SARS-CoV-2 specific NLRP3 and IL-1β responses in T cells of aging patients during acute COVID-19 infection

COVID‐19 is an emergent disease of aging

A human circulating immune cell landscape in aging and COVID-19

Delayed bystander CD8 T cell activation, early immune pathology and persistent dysregulation characterise severe COVID-19